APA (7th ed.) Citation

V, D., V, H., M, B., V, P., C, E., M, L., . . . A, H. (2023). Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure-A Prospective Observational Study. Journal of clinical medicine, 12(23), . https://doi.org/10.3390/jcm12237200

Chicago Style (17th ed.) Citation

V, Dworok, Hähnel V, Bannehr M, Paar V, Edlinger C, Lichtenauer M, Butter C, and Haase-Fielitz A. "Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure-A Prospective Observational Study." Journal of Clinical Medicine 12, no. 23 (2023). https://doi.org/10.3390/jcm12237200.

MLA (9th ed.) Citation

V, Dworok, et al. "Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure-A Prospective Observational Study." Journal of Clinical Medicine, vol. 12, no. 23, 2023, https://doi.org/10.3390/jcm12237200.